Myfortic vs. Cellcept in Kidney Transplant Recipients
Condition(s):End Stage Renal DiseaseLast Updated:September 28, 2023Completed
Hide Studies Not Open or Pending
Condition(s):End Stage Renal DiseaseLast Updated:September 28, 2023Completed
Condition(s):HEPATITISLast Updated:March 3, 2014Unknown status
Condition(s):Kidney TransplantationLast Updated:July 5, 2019Terminated
Condition(s):Kidney TransplantationLast Updated:May 6, 2016Completed
Condition(s):Kidney TransplantLast Updated:November 11, 2015Completed
Condition(s):Prophylaxis of Organ RejectionLast Updated:January 23, 2018Completed
Condition(s):Infection; Transplant;Failure,KidneyLast Updated:May 6, 2022Withdrawn
Condition(s):Glomerulonephritis, MembranousLast Updated:April 10, 2015Unknown status
Condition(s):Lung Disease, InterstitialLast Updated:November 4, 2020Completed
Condition(s):End Stage Renal Disease (ESRD)Last Updated:April 28, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.